secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2023-03-17T23:59:59+00:00
Accession:  0001654954-23-003136
Event type: earnings
Sentiment:  positive
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv Q1 2023 revenue $4.2M (-$0.8M YoY); net income $0.4M (+$0.1M YoY)
--------------------------------------------------------------------------------

- Quarterly revenue $4.2M, down from $5.0M in prior-year quarter.
- Net income $0.4M, compared to $0.3M in same period last year.
- CEO cites resource optimization in profitable markets driving gross profit improvement.
- Company plans to continue maximizing resources to increase profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423003136/0001654954-23-003136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423003136/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-003136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer